Extractas Bioscience is a world leader in agricultural R&D and the extraction and purification of high value plant-derived products, with a particular focus on alkaloid raw materials used in the production of active pharmaceutical ingredients.

SK Capital acquired Extractas Bioscience and Noramco from Johnson & Johnson in July 2016.

For more information, please visit: https://extractas.com.au/